Can a new patch safely protect the brain after surgery?

NCT ID NCT07758790

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This registry study is evaluating the safety and performance of SYNTHECEL, a device used to close and protect the dura—the outer covering of the brain—during cranial surgery. Researchers will follow about 112 participants who undergo craniotomy or craniectomy and receive SYNTHECEL as part of their procedure. The study will track outcomes such as cerebrospinal fluid leakage, adhesion formation, and neurological status to see how well the device works in real-world clinical settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SYNTHECEL, a device used to close and protect the outer covering of the brain during cranial surgery
What this could lead to
If successful, this registry could provide real-world evidence on the safety and performance of SYNTHECEL, potentially supporting its broader use in routine cranial surgeries.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by variations in surgical practice and patient populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRANIOTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

  • Cleveland Clinic

    Weston, Florida, 33331 3609, United States

  • Kettering Medical Center

    Kettering, Ohio, 45429, United States

  • University of Kentucky

    Lexington, Kentucky, 40536, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.